• This record comes from PubMed

Cardio-ankle vascular index for predicting cardiovascular morbimortality and determinants for its progression in the prospective advanced approach to arterial stiffness (TRIPLE-A-Stiffness) study

. 2024 May ; 103 () : 105107. [epub] 20240417

Language English Country Netherlands Media print-electronic

Document type Journal Article, Multicenter Study

Links

PubMed 38632024
PubMed Central PMC11121166
DOI 10.1016/j.ebiom.2024.105107
PII: S2352-3964(24)00142-7
Knihovny.cz E-resources

BACKGROUND: The cardio-ankle vascular index (CAVI) measure of arterial stiffness is associated with prevalent cardiovascular risk factors, while its predictive value for cardiovascular events remains to be established. The aim was to determine associations of CAVI with cardiovascular morbimortality (primary outcome) and all-cause mortality (secondary outcome), and to establish the determinants of CAVI progression. METHODS: TRIPLE-A-Stiffness, an international multicentre prospective longitudinal study, enrolled >2000 subjects ≥40 years old at 32 centres from 18 European countries. Of these, 1250 subjects (55% women) were followed for a median of 3.82 (2.81-4.69) years. FINDINGS: Unadjusted cumulative incidence rates of outcomes according to CAVI stratification were higher in highest stratum (CAVI > 9). Cox regression with adjustment for age, sex, and cardiovascular risk factors revealed that CAVI was associated with increased cardiovascular morbimortality (HR 1.25 per 1 increase; 95% confidence interval, CI: 1.03-1.51) and all-cause mortality (HR 1.37 per 1 increase; 95% CI: 1.10-1.70) risk in subjects ≥60 years. In ROC analyses, CAVI optimal threshold was 9.25 (c-index 0.598; 0.542-0.654) and 8.30 (c-index 0.565; 0.512-0.618) in subjects ≥ or <60 years, respectively, to predict increased CV morbimortality. Finally, age, mean arterial blood pressure, anti-diabetic and lipid-lowering treatment were independent predictors of yearly CAVI progression adjusted for baseline CAVI. INTERPRETATION: The present study identified additional value for CAVI to predict outcomes after adjustment for CV risk factors, in particular for subjects ≥60 years. CAVI progression may represent a modifiable risk factor by treatments. FUNDING: International Society of Vascular Health (ISVH) and Fukuda Denshi, Japan.

Almazov Federal Medical Research Centre St Petersburg Russia

Cardiometabolic Centre Dept of Angiology Szent Imre University Teaching Hospital Budapest Hungary

Department of Internal Medicine and Geriatric Cardiology Centre of Postgraduate Medical Education Warsaw Poland

Department of Internal Medicine and Gerontology Jagiellonian University Medical College Kraków Poland

Department of Internal Medicine Hospital Mutua Terrassa University of Barcelona Terrassa Spain

Department of Medical Clinical Pharmacology University of Debrecen Hungary

Department of Medicine Section of Geriatric Medicine University of Verona Italy

Department of Medicine Solna Karolinska Institutet and Department of Cardiology Karolinska University Hospital Stockholm Sweden

Department of Medicine Solna Karolinska Institutet and Department of Cardiology Karolinska University Hospital Stockholm Sweden; Inserm U1116 Nancy France; Université de Lorraine CHRU Nancy University Hospital of Nancy France

Department of Nephrology Hypertension Dialysis and Transplantation University Hospital Centre Zagreb Croatia

Department of Preventive Cardiology Institute for Clinical and Experimental Medicine Prague Czech Republic

Foundation Medical Research Institutes Paris France

FSBI Chazov National Medical Research Centre of Cardiology of the Ministery of Health of the Russian Federation Moscow Russia

Government Institution L T Malaya Therapy Institute of the National Academy of Medical Sciences of Ukraine Kharkov Ukraine

Inserm U1116 Nancy France

Inserm U1116 Nancy France; Université de Lorraine CHRU Nancy University Hospital of Nancy France

Institut Universitari d'Investigació en Atenció Primària Jordi Gol Department of Medical Sciences University of Girona Primary Care Services Biomedical Research Institute Institut Català de la Salut Girona Spain

Institute of Cardiology Centre of Preventive Cardiology Yerevan Armenia

Institute of Cardiology Kiev Ukraine

Medical Faculty University of Belgrade and Cardiovascular Institute Dedinje Belgrade Serbia

P Stradins University Hospital Cardiology Centre Riga Latvia

Paris Descartes University AP HP Diagnosis and Therapeutic Center Hôtel Dieu Paris France

Primary Care Research Unit of Salamanca Department of Biomedical and Diagnostic Sciences University of Salamanca Salamanca Spain

Scientific and Research Institute of Cardiology and Internal Diseases Almaty Kazakhstan

Université de Lorraine CHRU Nancy University Hospital of Nancy France

See more in PubMed

Shirai K., Utino J., Otsuka K., Takata M. A novel blood pressure-independent arterial wall stiffness parameter; cardio-ankle vascular index (CAVI) J Atheroscler Thromb. 2006;13:101–107. PubMed

Topouchian J., Labat C., Gautier S., et al. Effects of metabolic syndrome on arterial function in different age groups: the Advanced Approach to Arterial Stiffness study. J Hypertens. 2018;36:824–833. PubMed PMC

Gomez-Sanchez L., Garcia-Ortiz L., Patino-Alonso M.C., et al. The association between the cardio-ankle vascular index and other parameters of vascular structure and function in caucasian adults: MARK study. J Atheroscler Thromb. 2015;22:901–911. PubMed

Kadoglou N.P.E., Moulakakis K.G., Mantas G., et al. The association of arterial stiffness with significant carotid atherosclerosis and carotid plaque vulnerability. Angiology. 2022;73:668–674. PubMed

Matsushita K., Ding N., Kim E.D., et al. Cardio-ankle vascular index and cardiovascular disease: systematic review and meta-analysis of prospective and cross-sectional studies. J Clin Hypertens. 2019;21:16–24. PubMed PMC

Williams B., Mancia G., Spiering W., et al. 2018 ESC/ESH guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European society of cardiology (ESC) and the European society of hypertension (ESH) Eur Heart J. 2018;39:3021–3104. PubMed

Shirai K., Takahara A. In: Cardio-ankle vascular index overview & clinical application. Asmar R., editor. 2021. The principles of cardio-ankle vascular index (CAVI) and its features; pp. 19–24.

Kubota Y., Maebuchi D., Takei M., et al. Cardio-Ankle Vascular Index is a predictor of cardiovascular events. Artery Research. 2011;5:91–96.

Miyoshi T., Ito H., Shirai K., et al. Predictive value of the cardio-ankle vascular index for cardiovascular events in patients at cardiovascular risk. J Am Heart Assoc. 2021;10 PubMed PMC

Spronck B., Obeid M.J., Paravathaneni M., et al. Predictive ability of pressure-corrected arterial stiffness indices: comparison of pulse wave velocity, cardio-ankle vascular index (CAVI), and CAVI0. Am J Hypertens. 2022;35:272–280. PubMed PMC

Schillaci G., Battista F., Settimi L., Anastasio F., Pucci G. Cardio-ankle vascular index and subclinical heart disease. Hypertens Res. 2015;38:68–73. PubMed

Laucevicius A., Ryliskyte L., Balsyte J., et al. Association of cardio-ankle vascular index with cardiovascular risk factors and cardiovascular events in metabolic syndrome patients. Medicina (Kaunas) 2015;51:152–158. PubMed

Sato Y., Nagayama D., Saiki A., et al. Cardio-ankle vascular index is independently associated with future cardiovascular events in outpatients with metabolic disorders. J Atheroscler Thromb. 2016;23:596–605. PubMed

Satoh-Asahara N., Kotani K., Yamakage H., et al. Cardio-ankle vascular index predicts for the incidence of cardiovascular events in obese patients: a multicenter prospective cohort study (Japan Obesity and Metabolic Syndrome Study: joms) Atherosclerosis. 2015;242:461–468. PubMed

Otsuka K., Fukuda S., Shimada K., et al. Serial assessment of arterial stiffness by cardio-ankle vascular index for prediction of future cardiovascular events in patients with coronary artery disease. Hypertens Res. 2014;37:1014–1020. PubMed

Miyoshi T., Ito H., Horinaka S., Shirai K., Higaki J., Orimo H. Protocol for evaluating the cardio-ankle vascular index to predict cardiovascular events in Japan: a prospective multicenter cohort study. Pulse (Basel) 2017;4:11–16. PubMed PMC

Sahebkar A., Pecin I., Tedeschi-Reiner E., Derosa G., Maffioli P., Reiner Z. Effects of statin therapy on augmentation index as a measure of arterial stiffness: a systematic review and meta-analysis. Int J Cardiol. 2016;212:160–168. PubMed

Asmar R. Principles and usefulness of the cardio-ankle vascular index (CAVI): a new global arterial stiffness index. Eur Heart J Suppl. 2017;19:B4–B10.

VanderWeele T.J. Principles of confounder selection. Eur J Epidemiol. 2019;34:211–219. PubMed PMC

Find record

Citation metrics

Loading data ...

Archiving options

Loading data ...